Technology<\/p>\n\n\n\n
Scalp Cooling System<\/p>\n\n\n\n
Season 3 Episode 11<\/p>\n\n\n\n About the Product<\/strong><\/p>\n\n\n\n Introducing Eva – India’s inaugural Scalp Cooling System, dedicated to mitigating chemotherapy-induced hair loss and positively impacting lives. Their ISO13485 Quality Certification underscores their commitment to maintaining superior standards. With registration under CDSCO, they ensure compliance and reliability, while the backing of the Department of Biotechnology (DST, GOI) signifies governmental support for their innovative approach. Eva is now accessible in handpicked Cancer Centres, ensuring specialized care for patients.<\/p>\n\n\n\n Eva’s flagship solution, the Eva Next Gen Duo 2000, stands as a beacon of pioneering innovation in India’s medical landscape. Designed for advanced hair preservation, it represents a significant leap forward in addressing the challenges faced by chemotherapy patients. Meanwhile, the Eva SmartFit Cool Wrap offers a universal fit, accommodating all head sizes for unparalleled comfort and efficacy. Its adaptability ensures that every patient experiences optimal ease throughout their treatment journey.<\/p>\n\n\n\n Through their commitment to minimizing hair loss, Eva not only preserves a natural appearance during chemotherapy but also upholds the positive self-image crucial for supporting overall well-being during treatment. By alleviating concerns about hair loss, Eva encourages patients to adhere to their treatment regimens consistently, thereby enhancing treatment outcomes and patient satisfaction. Furthermore, Eva’s non-invasive and patient-friendly design, featuring a cooling cap, prioritizes comfort and convenience, underscoring their dedication to ensuring a supportive and dignified experience for every individual undergoing treatment.<\/p>\n\n\n\nBrand<\/strong><\/td> Eva<\/td><\/tr> Company Name<\/strong><\/td> Stemtech Medical Devices<\/td><\/tr> Founders<\/strong><\/td> Raghuveer Surupa<\/td><\/tr> Original Ask<\/strong><\/td> 30 lakhs for 1.25% equity at the valuation of Rs. 25 crores<\/td><\/tr> Deal<\/strong><\/td> 30 lakhs for 1.8% equity at the valuation of Rs. 16.67 crores<\/td><\/tr><\/tbody><\/table><\/figure>\n\n\n\n